TY - JOUR
T1 - Higher predictive value positive for MMA than ACA MTM eligibility criteria among racial and ethnic minorities
T2 - An observational study
AU - Qiao, Yanru
AU - Spivey, Christina A.
AU - Wang, Junling
AU - Shih, Ya Chen Tina
AU - Wan, Jim Y.
AU - Kuhle, Julie
AU - Dagogo-Jack, Samuel
AU - Cushman, William C.
AU - Chisholm-Burns, Marie A.
N1 - Publisher Copyright:
© The Author(s) 2018.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - The objective of this study was to examine positive predictive value (PPV) of medication therapy management (MTM) eligibility criteria under Medicare Modernization Act (MMA) and Affordable Care Act (ACA) in identifying patients with medication utilization issues across racial and ethnic groups. The study analyzed Medicare data (2012-2013) for 2 213 594 beneficiaries. Medication utilization issues were determined based on medication utilization measures mostly developed by Pharmacy Quality Alliance. MMA was associated with higher PPV than ACA in identifying individuals with medication utilization issues among non-Hispanic blacks (blacks) and Hispanics than non-Hispanic whites (whites). For example, odds ratio for having medication utilization issues to whites when examining MMA in 2013 and ACA were 1.09 (95% confidence interval [CI] = 1.04-1.15) among blacks, and 1.17 (95% CI = 1.10-1.24) among Hispanics, in the main analysis. Therefore, MMA was associated with 9% and 17% higher PPV than ACA in identifying patients with medication utilization issues among blacks and Hispanics, respectively, than whites.
AB - The objective of this study was to examine positive predictive value (PPV) of medication therapy management (MTM) eligibility criteria under Medicare Modernization Act (MMA) and Affordable Care Act (ACA) in identifying patients with medication utilization issues across racial and ethnic groups. The study analyzed Medicare data (2012-2013) for 2 213 594 beneficiaries. Medication utilization issues were determined based on medication utilization measures mostly developed by Pharmacy Quality Alliance. MMA was associated with higher PPV than ACA in identifying individuals with medication utilization issues among non-Hispanic blacks (blacks) and Hispanics than non-Hispanic whites (whites). For example, odds ratio for having medication utilization issues to whites when examining MMA in 2013 and ACA were 1.09 (95% confidence interval [CI] = 1.04-1.15) among blacks, and 1.17 (95% CI = 1.10-1.24) among Hispanics, in the main analysis. Therefore, MMA was associated with 9% and 17% higher PPV than ACA in identifying patients with medication utilization issues among blacks and Hispanics, respectively, than whites.
KW - Continental population groups
KW - Drug utilization
KW - Efficiency
KW - Ethnic groups
KW - Hispanic Americans
KW - Medicare prescription drug and modernization act of 2003
KW - Medication therapy management
KW - Patient protection and affordable care act
KW - Predictive value of tests
UR - http://www.scopus.com/inward/record.url?scp=85056391200&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056391200&partnerID=8YFLogxK
U2 - 10.1177/0046958018795749
DO - 10.1177/0046958018795749
M3 - Article
C2 - 30175638
AN - SCOPUS:85056391200
SN - 0046-9580
VL - 55
JO - Inquiry (United States)
JF - Inquiry (United States)
ER -